Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $77.33 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Canon Medical Systems USA, Inc. | $26.20 | 1 | $0 (2021) |
| Pharmacyclics LLC, An AbbVie Company | $21.27 | 1 | $0 (2019) |
| Clovis Oncology, Inc. | $15.51 | 1 | $0 (2017) |
| Millennium Pharmaceuticals, Inc. | $14.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $26.20 | 1 | Canon Medical Systems USA, Inc. ($26.20) |
| 2019 | $21.27 | 1 | Pharmacyclics LLC, An AbbVie Company ($21.27) |
| 2017 | $29.86 | 2 | Clovis Oncology, Inc. ($15.51) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/01/2021 | Canon Medical Systems USA, Inc. | DIAGNOSTIC ULTRASOUND SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $26.20 | General |
| Category: TUS-AI700 | ||||||
| 04/09/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Oncology | ||||||
| 10/10/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Oncology | ||||||
| 04/06/2017 | Millennium Pharmaceuticals, Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 462 | 480 | $41,819 | $10,686 |
| 2022 | 54 | 3,418 | 3,681 | $316,030 | $78,407 |
| 2021 | 64 | 5,738 | 6,249 | $557,328 | $143,333 |
| 2020 | 64 | 5,271 | 5,756 | $477,819 | $127,322 |
All Medicare Procedures & Services
201 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Facility | 2023 | 67 | 67 | $7,839 | $2,460 | 31.4% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 67 | 67 | $6,164 | $1,956 | 31.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 27 | 27 | $7,587 | $1,668 | 22.0% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 17 | 17 | $4,760 | $1,184 | 24.9% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 18 | 18 | $3,222 | $704.84 | 21.9% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 14 | 14 | $2,674 | $523.48 | 19.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 63 | 74 | $2,072 | $490.59 | 23.7% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 64 | 64 | $2,176 | $382.05 | 17.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 30 | 30 | $900.00 | $286.80 | 31.9% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 13 | 13 | $1,196 | $281.08 | 23.5% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 14 | 14 | $966.00 | $223.08 | 23.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Facility | 2023 | 16 | 18 | $522.00 | $125.80 | 24.1% |
| 73630 | X-ray of foot, minimum of 3 views | Facility | 2023 | 13 | 16 | $494.00 | $111.51 | 22.6% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Facility | 2023 | 11 | 11 | $341.00 | $109.12 | 32.0% |
| 73560 | X-ray of knee, 1-2 views | Facility | 2023 | 14 | 16 | $416.00 | $91.98 | 22.1% |
| 73502 | X-ray of hip, 2-3 views | Facility | 2023 | 14 | 14 | $490.00 | $87.60 | 17.9% |
| 77067 | Screening mammography | Facility | 2022 | 445 | 445 | $51,653 | $16,573 | 32.1% |
| 77063 | Screening 3d breast mammography | Facility | 2022 | 443 | 443 | $40,345 | $13,234 | 32.8% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2022 | 119 | 128 | $35,730 | $7,917 | 22.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2022 | 73 | 75 | $19,962 | $4,610 | 23.1% |
| 71260 | Ct scan of chest with contrast | Facility | 2022 | 79 | 87 | $16,540 | $3,421 | 20.7% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 79 | 81 | $14,421 | $2,966 | 20.6% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 43 | 43 | $11,923 | $2,435 | 20.4% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 247 | 279 | $9,486 | $1,943 | 20.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 194 | 194 | $5,820 | $1,914 | 32.9% |
About Dr. John Kustan, M.D
Dr. John Kustan, M.D is a Diagnostic Radiology healthcare provider based in North Conway, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386625077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kustan, M.D has received a total of $77.33 in payments from pharmaceutical and medical device companies, with $26.20 received in 2021. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($77.33).
As a Medicare-enrolled provider, Kustan has provided services to 14,889 Medicare beneficiaries, totaling 16,166 services with total Medicare billing of $359,748. Data is available for 4 years (2020–2023), covering 201 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location North Conway, NH
- Active Since 11/09/2005
- Last Updated 11/04/2015
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1386625077
Products in Payments
- DIAGNOSTIC ULTRASOUND SYSTEM (Device) $26.20
- Imbruvica (Drug) $21.27
- Rubraca (Drug) $15.51
- NINLARO (Drug) $14.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.